1
|
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.
|
N Engl J Med
|
2006
|
6.14
|
2
|
Weight loss to treat urinary incontinence in overweight and obese women.
|
N Engl J Med
|
2009
|
5.58
|
3
|
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.
|
Ann Intern Med
|
2003
|
5.38
|
4
|
The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence.
|
Ann Intern Med
|
2006
|
3.93
|
5
|
Evidence-based guidelines for cardiovascular disease prevention in women.
|
Circulation
|
2004
|
3.39
|
6
|
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
|
JAMA
|
2002
|
3.13
|
7
|
Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study.
|
Arch Intern Med
|
2011
|
3.00
|
8
|
Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial.
|
JAMA
|
2002
|
2.73
|
9
|
Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis.
|
Arch Intern Med
|
2002
|
2.69
|
10
|
The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis.
|
J Am Coll Cardiol
|
2006
|
2.64
|
11
|
Diagnostic tests: another frontier for less is more: or why talking to your patient is a safe and effective method of reassurance.
|
Arch Intern Med
|
2010
|
2.49
|
12
|
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors.
|
Circulation
|
2009
|
2.41
|
13
|
Serum lipoprotein levels, statin use, and cognitive function in older women.
|
Arch Neurol
|
2002
|
2.41
|
14
|
Evaluation of abnormal mammography results and palpable breast abnormalities.
|
Ann Intern Med
|
2003
|
2.20
|
15
|
Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women.
|
Menopause
|
2009
|
2.07
|
16
|
Postmenopausal hormone therapy: does it cause incontinence?
|
Obstet Gynecol
|
2005
|
1.94
|
17
|
Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy.
|
Obstet Gynecol
|
2003
|
1.85
|
18
|
Less is more: how less health care can result in better health.
|
Arch Intern Med
|
2010
|
1.77
|
19
|
Comparison of methods to measure low serum estradiol levels in postmenopausal women.
|
J Clin Endocrinol Metab
|
2006
|
1.76
|
20
|
Predictors of heart failure among women with coronary disease.
|
Circulation
|
2004
|
1.74
|
21
|
The WHI estrogen-alone trial--do things look any better?
|
JAMA
|
2004
|
1.64
|
22
|
Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial.
|
Am J Psychiatry
|
2005
|
1.62
|
23
|
Sex hormone levels and risk of breast cancer with estrogen plus progestin.
|
J Natl Cancer Inst
|
2013
|
1.60
|
24
|
Evidence-based guidelines for cardiovascular disease prevention in women.
|
J Am Coll Cardiol
|
2004
|
1.59
|
25
|
Menopausal symptoms in older women and the effects of treatment with hormone therapy.
|
Obstet Gynecol
|
2002
|
1.57
|
26
|
Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
1.55
|
27
|
The "costs" of urinary incontinence for women.
|
Obstet Gynecol
|
2006
|
1.52
|
28
|
Opioids for chronic pain.
|
Arch Intern Med
|
2011
|
1.52
|
29
|
Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement.
|
Arterioscler Thromb Vasc Biol
|
2004
|
1.49
|
30
|
Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease.
|
Arterioscler Thromb Vasc Biol
|
2002
|
1.48
|
31
|
Why is a good clinical prediction rule so hard to find?
|
Arch Intern Med
|
2011
|
1.38
|
32
|
Editor's Note--to make the case--evidence is required: comment on "Making the case for selective use of statins in the primary prevention setting".
|
Arch Intern Med
|
2011
|
1.33
|
33
|
Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months.
|
J Urol
|
2010
|
1.31
|
34
|
Persistent hot flushes in older postmenopausal women.
|
Arch Intern Med
|
2008
|
1.28
|
35
|
Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes.
|
Menopause
|
2009
|
1.23
|
36
|
Feasibility and acceptability of restorative yoga for treatment of hot flushes: a pilot trial.
|
Maturitas
|
2006
|
1.22
|
37
|
Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women.
|
Biol Psychiatry
|
2002
|
1.11
|
38
|
Association of total and central obesity with mortality in postmenopausal women with coronary heart disease.
|
Am J Epidemiol
|
2003
|
1.10
|
39
|
Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life.
|
Arch Neurol
|
2006
|
1.10
|
40
|
Commentary: Improving participant recruitment in clinical and translational research.
|
Acad Med
|
2011
|
1.09
|
41
|
Dopamine receptor D4 (DRD4) gene in Han Chinese children with attention-deficit/hyperactivity disorder (ADHD): increased prevalence of the 2-repeat allele.
|
Am J Med Genet B Neuropsychiatr Genet
|
2005
|
1.08
|
42
|
Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial.
|
Obstet Gynecol
|
2004
|
1.06
|
43
|
The rise and fall of menopausal hormone therapy.
|
Annu Rev Public Health
|
2005
|
1.04
|
44
|
A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer.
|
Breast Cancer Res Treat
|
2010
|
1.03
|
45
|
Adaptive statistical iterative reconstruction reduces patient radiation dose in neuroradiology CT studies.
|
Neuroradiology
|
2014
|
1.01
|
46
|
An intensive behavioral weight loss intervention and hot flushes in women.
|
Arch Intern Med
|
2010
|
1.00
|
47
|
Restorative yoga in adults with metabolic syndrome: a randomized, controlled pilot trial.
|
Metab Syndr Relat Disord
|
2008
|
1.00
|
48
|
Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease.
|
Stroke
|
2008
|
0.97
|
49
|
Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial.
|
Am J Cardiol
|
2002
|
0.96
|
50
|
Renal insufficiency as an independent predictor of mortality among women with heart failure.
|
J Am Coll Cardiol
|
2004
|
0.94
|
51
|
Effects of raloxifene on fracture risk in postmenopausal women: the Raloxifene Use for the Heart Trial.
|
J Bone Miner Res
|
2008
|
0.93
|
52
|
The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women.
|
Obstet Gynecol
|
2005
|
0.91
|
53
|
Raloxifene and risk for stroke based on the framingham stroke risk score.
|
Am J Med
|
2009
|
0.87
|
54
|
Clinical trials in stem cell transplantation: guidelines for scientific and ethical review.
|
Clin Trials
|
2008
|
0.86
|
55
|
I Just Feel Terrible: Comment on "Why Physicians Work When Sick"I Just Feel Terrible.
|
Arch Intern Med
|
2012
|
0.85
|
56
|
Uterine and vaginal effects of unopposed ultralow-dose transdermal estradiol.
|
Obstet Gynecol
|
2005
|
0.84
|
57
|
Postmenopausal hormone therapy.
|
BMJ
|
2007
|
0.83
|
58
|
Soy isoflavones for prevention of menopausal bone loss and vasomotor symptoms: comment on "Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms".
|
Arch Intern Med
|
2011
|
0.82
|
59
|
Strengthening institutional review board review of highly innovative interventions in clinical trials.
|
JAMA
|
2009
|
0.82
|
60
|
Hot flushes, bone mineral density, and fractures in older postmenopausal women.
|
Obstet Gynecol
|
2007
|
0.81
|
61
|
Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women.
|
Arterioscler Thromb Vasc Biol
|
2004
|
0.81
|
62
|
Alternatives to estrogen for treatment of hot flashes: are they effective and safe?
|
JAMA
|
2006
|
0.81
|
63
|
The day-to-day impact of urogenital aging: perspectives from racially/ethnically diverse women.
|
J Gen Intern Med
|
2009
|
0.81
|
64
|
Oophorectomy as a risk factor for coronary heart disease.
|
Am J Obstet Gynecol
|
2008
|
0.80
|
65
|
Developing methods for less is more.
|
JAMA Intern Med
|
2014
|
0.80
|
66
|
Miniature ambulatory skin conductance monitor and algorithm for investigating hot flash events.
|
Physiol Meas
|
2014
|
0.79
|
67
|
Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
|
J Child Adolesc Psychopharmacol
|
2007
|
0.79
|
68
|
Evaluation of monoenergetic imaging to reduce metallic instrumentation artifacts in computed tomography of the cervical spine.
|
J Neurosurg Spine
|
2015
|
0.79
|
69
|
Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
|
Menopause
|
2006
|
0.78
|
70
|
Undertreatment improves, but overtreatment does not.
|
JAMA Intern Med
|
2013
|
0.78
|
71
|
A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder.
|
Am Heart J
|
2011
|
0.78
|
72
|
Raloxifene and colorectal cancer.
|
J Womens Health (Larchmt)
|
2005
|
0.78
|
73
|
Placebo adherence and mortality in the Heart and Estrogen/Progestin Replacement Study.
|
Am J Med
|
2012
|
0.77
|
74
|
The flip side of performance measures: limiting overtreatment.
|
Arch Intern Med
|
2012
|
0.76
|
75
|
Device-guided slow-paced respiration for menopausal hot flushes: a randomized controlled trial.
|
Obstet Gynecol
|
2015
|
0.76
|
76
|
Improving care at the end of life.
|
Arch Intern Med
|
2011
|
0.75
|
77
|
Conservative use of prescription drugs: comment on "Communicating uncertainties about prescription drugs to the public".
|
Arch Intern Med
|
2011
|
0.75
|
78
|
Evidence in clinical practice.
|
Arch Intern Med
|
2012
|
0.75
|
79
|
Spinal augmentation for vertebral fracture.
|
JAMA Intern Med
|
2013
|
0.75
|
80
|
Approaches to increase physical activity.
|
JAMA Intern Med
|
2014
|
0.75
|
81
|
Helping women stop postmenopausal hormone therapy.
|
Menopause
|
2006
|
0.75
|
82
|
Another reason to be cautious about imaging: comment on "association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism".
|
Arch Intern Med
|
2012
|
0.75
|
83
|
Invited commentary--illuminating physicians' financial relationships with industry.
|
Arch Intern Med
|
2011
|
0.75
|
84
|
Postmenopausal hormone treatment.
|
JAMA
|
2009
|
0.75
|
85
|
Why physicians order tests.
|
JAMA Intern Med
|
2013
|
0.75
|
86
|
Testing before seeing the patient.
|
JAMA Intern Med
|
2015
|
0.75
|
87
|
How Much Vitamin D Is Enough?
|
JAMA Intern Med
|
2015
|
0.75
|
88
|
Myocardial infarction during menses: lessons from trials and errors.
|
Am J Med
|
2003
|
0.75
|
89
|
The "top 5" health care activities for which less is more: comment on "The 'top 5' lists in primary care".
|
Arch Intern Med
|
2011
|
0.75
|
90
|
Electrocardiograms of menopausal women with coronary heart disease or at increased risk for its occurrence.
|
Am J Cardiol
|
2010
|
0.75
|
91
|
On board with the Choosing Wisely campaign.
|
JAMA Intern Med
|
2014
|
0.75
|
92
|
I just feel terrible.
|
Arch Intern Med
|
2012
|
0.75
|
93
|
Reasons for overtreatment: comment on "Too little? Too much? Primary care physicians' views on US health care".
|
Arch Intern Med
|
2011
|
0.75
|
94
|
Continuous transdermal nitroglycerin therapy for menopausal hot flashes: a single-arm, dose-escalation trial.
|
Menopause
|
2016
|
0.75
|
95
|
A Simple Approach to Reducing Inappropriate Use of Central Venous Catheters.
|
JAMA Intern Med
|
2015
|
0.75
|
96
|
A different perspective regarding prostate-specific antigen testing: in reply.
|
Arch Intern Med
|
2012
|
0.75
|
97
|
Letters to the Editor.
|
Menopause
|
2016
|
0.75
|
98
|
Improving quality of care at the end of life.
|
Arch Intern Med
|
2012
|
0.75
|
99
|
Planning for closeout--from Day One.
|
Contemp Clin Trials
|
2007
|
0.75
|
100
|
The effect of ultralow-dose transdermal estradiol on sexual function in postmenopausal women.
|
Am J Obstet Gynecol
|
2008
|
0.75
|
101
|
Effect of hormone therapy on mortality rates among women with heart failure and coronary artery disease.
|
Am J Cardiol
|
2005
|
0.75
|
102
|
Simplification of Insulin Regimens in Patients With Type 2 Diabetes.
|
JAMA Intern Med
|
2016
|
0.75
|
103
|
Cardiac autonomic function and hot flashes among perimenopausal and postmenopausal women.
|
Menopause
|
2017
|
0.75
|
104
|
Let's Get Another Tube-Just in Case.
|
JAMA Intern Med
|
2016
|
0.75
|
105
|
Sleeping on the Street.
|
JAMA Intern Med
|
2016
|
0.75
|
106
|
In Reply.
|
Menopause
|
2017
|
0.75
|
107
|
Patient experience of overtreatment.
|
Arch Intern Med
|
2011
|
0.75
|